Cargando…
DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment
In this study, we investigated the feasibility of dipalmitoylphosphatidylcholine-coated lipid nanoparticles (DPPC-LNs) as a carrier for preferential accumulation into lungs of Resveratrol (Res), a potentially promising drug for the treatment of pulmonary arterial hypertension (PAH). Res-loaded DPPC-...
Autores principales: | Li, Zerong, Qiao, Wenmei, Wang, Chenghao, Wang, Heqiao, Ma, Mengchao, Han, Xinyu, Tang, Jingling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269040/ https://www.ncbi.nlm.nih.gov/pubmed/32397765 http://dx.doi.org/10.1080/10717544.2020.1760962 |
Ejemplares similares
-
In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
por: Xu, Hongfei, et al.
Publicado: (2021) -
Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery
por: Duan, Jinghua, et al.
Publicado: (2013) -
Unraveling the pulmonary drug delivery carriers in inhalable nanostructures
por: Huang, Zhengwei, et al.
Publicado: (2022) -
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC
por: Becker-Pelster, Eva M., et al.
Publicado: (2022) -
COVID-19 and the pulmonary vasculature
por: Provencher, Steeve, et al.
Publicado: (2020)